Company profile:

TTL Clinical is a Contract Research Organization (CRO), providing expertise in clinical research conducted in Central & Eastern Europe (CEE) as a part of multicentre, international research projects.
It is built on a staff with a long, unique experience in high-standard clinical research. The company is led by management representing years of experience in clinical research management collected in leading pharmaceutical companies and global CRO.
The company serves the clients from the pharmaceutical and biotechnology industry.

TTL Clinical offers wide spectrum of services in clinical research including:

• consulting
• auditing
• monitoring of clinical trials providing data management
• clinical project management
• repair of non-performing clinical projects
• preparation for local regulatory inspection

The U.S. office of the company ensures effective communication with our US clients. The European office is located in Poland and it cooperates also with clients from Europe and with local companies.
In recent years clinical studies conducted in Central and Eastern Europe (region with approx. 200 millions inhabitants) as a part of international research programs with study sites in Western, Central and Eastern Europe contributed significantly to drug approval in the USA, in Europe and, consequently, in CEE countries.
The key focus of the company is to provide innovative solutions to enhance patients recruitment and ensure high quality of collected clinical data. We also review thoroughly planned and ongoing clinical research processes identifying contingencies and proposing effective solutions to ensure smooth progress of the project and to select the most cost-effective approach. We utilize experience collected by our management in the past when they, as a part of the team, invented effective measures to improve management of clinical trials with an aim to decrease the average drug development time from 8 to 5.5 years and to improve quality of the collected data. This was monitored and documented by continuous measurement of performance metrics for the key deliverables.
Our organization is designed to achieve maximum flexibility reflecting changing research environment and to promote innovative processes, which should result in the shortening of drug development time.

Our watchword is: High quality clinical data on time.